Skip to content

Basket

You currently have no items in your basket.

Total (excl. vat) £0.00
View basket & checkout
Antibodies

ACT017

Product Sizes
1 mg
£ POA
HY-P99644-1MG
5 mg
£ POA
HY-P99644-5MG
10 mg
£ POA
HY-P99644-10MG
About this Product
SKU:
HY-P99644
CAS Number:
2101829-58-5
Extra Details:
ACT017 is a Fab fragment of humanized anti-GPVI monoclonal antibody. ACT017 inhibits collagen-induced platelet aggregation. ACT017 has the potential for the research of acute ischemic stroke[1][2].
Molecular Weight:
(48.29 kDa)
Purity:
99.00
References:
[1]Wichaiyo S, et al. Glenzocimab: A GPVI (Glycoprotein VI)-Targeted Potential Antiplatelet Agent for the Treatment of Acute Ischemic Stroke. Stroke. 2022 Nov;53(11):3506-3513. |[2]Lebozec K, et al. Design, development and characterization of ACT017, a humanized Fab that blocks platelet's glycoprotein VI function without causing bleeding risks. MAbs. 2017 Aug/Sep;9(6):945-958.
Research Area:
Cardiovascular Disease
Shipping Conditions:
Dry Ice
Storage Conditions:
Store at -80[o]C for 2 years
Type:
Antibodies
Pathway:
Immunology/Inflammation
Price enquiry form